Beacon Pointe Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Buy |
14,328
+1,174
| +9% | +$126K | 0.02% | 540 |
|
|
2025
Q1 | $1.33M | Sell |
13,154
-902
| -6% | -$91K | 0.01% | 563 |
|
|
2024
Q4 | $1.26M | Sell |
14,056
-6,853
| -33% | -$612K | 0.01% | 580 |
|
|
2024
Q3 | $1.75M | Sell |
20,909
-1,127
| -5% | -$94.4K | 0.02% | 494 |
|
|
2024
Q2 | $1.7M | Sell |
22,036
-542
| -2% | -$41.7K | 0.02% | 507 |
|
|
2024
Q1 | $1.55M | Buy |
22,578
+930
| +4% | +$63.7K | 0.02% | 555 |
|
|
2023
Q4 | $1.25M | Sell |
21,648
-703
| -3% | -$40.6K | 0.02% | 592 |
|
|
2023
Q3 | $1.18M | Buy |
22,351
+9,263
| +71% | +$489K | 0.01% | 578 |
|
|
2023
Q2 | $708K | Sell |
13,088
-2,005
| -13% | -$108K | 0.01% | 615 |
|
|
2023
Q1 | $755K | Buy |
15,093
+250
| +2% | +$12.5K | 0.01% | 624 |
|
|
2022
Q4 | $687K | Buy |
14,843
+1,785
| +14% | +$82.6K | 0.01% | 596 |
|
|
2022
Q3 | $500K | Buy |
13,058
+254
| +2% | +$9.73K | 0.01% | 638 |
|
|
2022
Q2 | $478K | Sell |
12,804
-7,548
| -37% | -$282K | 0.01% | 667 |
|
|
2022
Q1 | $901K | Buy |
20,352
+12,113
| +147% | +$536K | 0.01% | 651 |
|
|
2021
Q4 | $350K | Buy |
8,239
+358
| +5% | +$15.2K | 0.01% | 674 |
|
|
2021
Q3 | $342K | Buy |
7,881
+258
| +3% | +$11.2K | 0.01% | 657 |
|
|
2021
Q2 | $326K | Buy |
+7,623
| New | +$326K | 0.01% | 638 |
|